Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Monday
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Comment by sunshine7on May 21, 2016 8:52am
198 Views
Post# 24894955

RE:RE:RE:RE:Monday

RE:RE:RE:RE:Monday
curious, this and many other recent posts sums up my feelings exactly. CXR is very attractive to PE and is likely in the best interest of the company at this time. Any negotiations are very complex. Fair value IMO is US$65 based on CF and growth.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities